| Gene Set | Leading Edge Genes |
|---|
| SPIELMAN LYMPHOBLAST EUROPEAN VS ASIAN UP | ENO3, PIN1, SART1, NDUFA3, MAPK12, ACY1, GPX4, YBX1, MRPL23, NDUFA1, EI24, NDUFS8, BLOC1S1, DBI, PSMB5, NDUFS6, APRT, GMPS, TUBB, PQBP1, CST3, VPS4A, DHCR24, HSPB1, KIF22, PPIB, DDT, NDUFV2, ATPIF1, TAX1BP3, NUDT3, MAD1L1, TESK1, VRK1, ARPC4, NUDT1, HEBP2, FKBP3, RALY, CFDP1, NUBP2, TACC3, HSD17B4, KIF20A, HDAC1, NME4, ATP5G2, NDUFB8, GPX1, UBL5, TUBB3, PSMD4, CENPF, NSDHL, TBCA, UQCRC1, RPS27L, DCXR, CD2BP2, CDK2AP2, MBD3, CYB5B, UBE2C, BCAT2, LSM4, MLF2, BANF1, DPYSL2, HMBS, EBP, GNL2, RPL4, SCAND1, TCEB2, TAF10, PARK7, TSPAN3, H2AFX, HMGB1, NDUFA2, PGLS, EZH2, MEA1, HEXIM1, COX4I1, OAZ1, PSMD13, ETV5, CACYBP, COX6A1, CALM1, PKD1, APEX2, PSMB3, KCNK1, ARHGDIB, NACA |
| KEGG HUNTINGTONS DISEASE | NDUFA3, ATP5G2, NDUFB8, UQCRH, GPX1, NDUFA1, NDUFA7, NDUFS8, CYC1, POLR2J, NDUFA8, NDUFA6, UQCRC1, ATP5O, NDUFS6, NDUFS2, NDUFS3, NDUFC1, SDHB, NDUFA10, AP2M1, NDUFA2, AP2B1, NDUFS4, POLR2F, CLTB, COX4I1, NDUFB6, COX6A1, DCTN2, ATP5B, COX7C |
| KEGG ALZHEIMERS DISEASE | SDHB, CALM3, NDUFA3, ATP5G2, NDUFB8, UQCRH, ADAM10, NDUFA1, NDUFA10, NDUFS8, NDUFA8, NDUFA6, ATP5O, NDUFS6, NDUFS4, APH1A, COX4I1, CALM1, COX6A1, NDUFS2, NDUFB6, COX7C, ATP5B, NDUFS3, NDUFC1 |
| ACEVEDO LIVER TUMOR VS NORMAL ADJACENT TISSUE UP | CSTF2, CETN2, ILF2, HSP90AB1, MGST3, DYNLRB1, GMDS, SDF2L1, EXOSC5, BRP44, ICT1, HSPA14, NDUFA8, IGBP1, LGTN, PSMB5, MCM3, ATP5S, GMPS, SSR2, DUSP12, RNASEH2A, PIGT, COPB2, ACOT9, PAPSS1, CUEDC2, MRPL40, MRPL18, NHP2L1, RPL36AL, PSMD6, TAF12, NUDT1, SFRS2, IDH1, GTF2A2, NDUFB6, IDI1, VPS28, TFG, XRCC6, IFRD2, COPE, DHX29, BLVRA, UFC1, RAG1AP1, THAP11, APEX1, PIGC, WRB, ACP1, TOM1L1, SLC25A4, CCT8, LSM4, GOLPH3L, HAX1, GPKOW, SURF1, LRRC42, SERPINH1, VAMP5, OXA1L, TMED10, NEDD8, RPA3, UFM1, PPP1CA, CCNA2, CUL2, MEA1, PSMB2, PSMD2, BTF3, ANKRD49, COX6A1, SPCS1, PRC1, TRAPPC4, IK |
| REACTOME CELL CYCLE MITOTIC | KIF20A, PSMC5, SSNA1, PCNA, PPP2CB, CETN2, BUB1, ZWINT, PLK1, PSMA2, CCNB1, AURKB, CDK4, PSMB1, NUDC, PSMA4, PSMD4, RFC5, CENPF, NUP85, PSME1, PSMD14, PSMB5, MCM3, ACTR1A, TUBB, UBE2C, KNTC1, CDK5RAP2, RFC2, PSMB6, DCTN3, PSMC3, PPP2CA, ORC4L, RANGAP1, ITGB3BP, PSMC1, PSMB7, RPA3, MAD1L1, CCNA2, PSMA7, PSMB2, PSMD2, KIF18A, PSMD6, PSMD12, PSMD8, DCTN2, ODF2, PSMB3, KIF2C, BIRC5 |
| PAL PRMT5 TARGETS UP | KIF20A, INTS8, HN1, PPP1R7, CALM3, CETN2, TMPO, NDUFB8, GAS1, STMN1, AURKB, CDK4, SLBP, NCBP2, UBE2M, RFC5, EMP3, APEX1, PSMB5, TUFM, ECHS1, NUP88, COPS3, CAPG, CD99, CUEDC2, PSMC3, H2AFX, LOXL1, TSEN34, CTPS2, EIF1AY, CDC20, GSTZ1, PSMD6, GJA1, CFDP1, GCAT, TARDBP, TACC3, EHMT2 |
| FOURNIER ACINAR DEVELOPMENT LATE 2 | SQLE, CDKN3, POLE3, ZWINT, CLPB, TMPO, PLK1, RNF138, MRPL17, HPCAL1, PRPS1, PARP2, UCHL5, NUP85, CDCA3, HSP90B1, MCM3, EXOSC8, PDLIM7, PITRM1, TTC4, TIPIN, RNASEH2A, MELK, HMBS, RAI14, ACOT9, SH3TC1, GNB1, PAICS, LDLR, CDC45L, RPA3, COL4A2, PTPLAD1, UBE2N, UCK2, PSMB2, VRK1, CCT2, TUBG1, CALM1, PRDX3, H2AFV, PRC1, IDI1, KIF2C, NT5DC2, BIRC5 |
| NUYTTEN EZH2 TARGETS DN | CDKN3, ARHGEF10, RDBP, GMPR2, BUB1, TMPO, AURKB, PBK, RPL18, RFC5, CDCA3, SP3, EXOSC8, FIBP, ACTR1A, ANTXR1, RNF141, KIF22, YWHAQ, RNASEH2A, NDUFV2, MRPS16, HSBP1, GGA2, MDFIC, NUDT21, ETFB, HP1BP3, NUDT1, MKRN1, MARCH2, PEX19, IDI1, ODF2, TACC3, UMPS, KIF2C, BIRC5, KIF20A, MLYCD, ZWINT, PLK1, PRPS2, CCNB1, GART, PAK2, MRPS33, THOP1, SYPL1, SS18, TOPBP1, ARCN1, COPZ1, CENPF, CNOT1, DNAJC3, SLC29A1, CDK2AP2, UBE2C, CYB5B, MRP63, THYN1, COMMD4, BANF1, GPKOW, KNTC1, RAB13, ARL1, LSM5, HMBS, CDK5RAP2, FANCG, AZI1, LRP12, ITGB3BP, CMAS, H2AFX, RPA3, HMMR, HMGB1, CCNA2, MTMR4, ABHD11, AP2B1, LBR, ANP32A, GPD2, YIPF5, H2AFV, PRC1, RBM8A, IK, STIP1, NT5DC2, SRPRB, KCNK1 |
| BLUM RESPONSE TO SALIRASIB DN | KIF20A, HDAC1, MYCBP, CDKN3, PCNA, HN1, TOP2B, NME4, TMPO, PLK1, PRSS23, MRPL23, STMN1, TUBB3, AURKB, PBK, CARHSP1, RFC5, CENPF, HSPA14, GAMT, MCM3, ITGB1BP1, UBE2C, DHCR24, HSPB1, RNASEH2A, EBP, PXMP2, RFC2, CDC45L, ITGB3BP, HMMR, CCNA2, CYB5A, OAZ2, VRK1, CDC20, SFRS2, PRDX3, MRE11A, CHST12, GPSM2, CRIP2, PRC1, TACC3 |
| MISSIAGLIA REGULATED BY METHYLATION DN | CDKN3, PAICS, ZWINT, STMN1, RPA3, HMGB1, CCNA2, RFC5, ITGB4, GMPS, LBR, ACAT2, UBE2C, CBARA1, RNASEH2A, PRC1, NDUFS3, KNTC1, EBP |
| TARTE PLASMA CELL VS PLASMABLAST DN | MYCBP, CDKN3, PSMC5, PCNA, TOP2B, TMPO, UQCRH, PRPS2, PSMA2, YBX1, GART, CCNB1, MRPL23, PAK2, CBX5, PPP4C, PSMD4, HSPE1, TOPBP1, ICT1, DBI, PSMD14, ATP5O, MCM3, UBE2C, TCP1, DHCR24, KIF22, UQCRC2, EBP, HSPA4, NDUFV2, CLIC1, GNB1, SDHB, PAICS, SNRPD3, TAX1BP3, PHB, HMMR, CCNA2, COASY, ANXA6, PSMB2, LBR, CCT5, ANP32A, FDFT1, IDH2, KIF2C, ARHGDIB, XRCC6, UFD1L |
| YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 14 | SERPINH1, HTRA2, RGS19, THOP1, TUBB3, CDK4, YKT6, EIF2B5, SNRPD3, UBE2M, MRPS28, APEX1, PSMB5, DDX41, PSMD6, CCT8, EBNA1BP2, SSR2, SMYD2, PDIA4, NSBP1, PREP, SEC61A1, RCN1, LMAN2, PSMB3, BANF1 |
| NCI ORC1 REMOVAL FROM CHROMATIN | PSMC5, PSMA2, PSMB6, PSMC3, ORC4L, PSMB1, PSMC1, PSMA4, PSMB7, PSMD9, PSMA7, PSME1, PSMD14, PSMB2, PSMD2, MCM3, PSMB5, PSMD6, PSMD13, PSMD12, PSMD8, PSMB3 |
| NCI SCF SKP2 MEDIATED DEGRADATION OF P27 P21 | PSMC5, PSMA2, PSMB6, PSMB1, PSMC3, PSMC1, PSMA4, PSMD9, PSMB7, PSMA7, PSME1, PSMB2, PSMD2, PSMB5, PSMD6, PSMD12, PSMD13, PSMD8, PSMB3 |
| LINDGREN BLADDER CANCER CLUSTER 3 UP | PCNA, CSTF2, TAF11, TMPO, PLK1, PRPS2, PEPD, ATG5, CCNB1, STMN1, PSMD11, ASS1, CENPF, DBI, PIGC, TOM1L1, UBE2C, TMEM106C, ZNF148, MELK, RNASEH2A, AK2, COPB2, EBP, LIG3, MRPS12, RPA3, NEDD9, VRK1, INSIG1, PGM3, SUCLG1, GLO1, PRC1, TACC3, IDH2, MRPL48, TFG, BIRC5 |
| CORUM PA700-20S-PA28 COMPLEX | PSMC5, PSMA2, PSMB6, PSMB1, PSMC3, PSMC1, PSMA4, PSMD9, PSMB7, PSMA7, PSME1, PSMB2, PSMD2, PSMB5, PSMD6, PSMD12, PSMD13, PSMD8, PSMB3 |
| NCI REGULATION OF ACTIVATED PAK 2P34 BY PROTEASOME MEDIATED DEGRADATION1 | PSMC5, PSMA2, PSMB6, PSMB1, PSMC3, PSMC1, PSMA4, PSMD9, PSMB7, PSMA7, PSME1, PSMB2, PSMD2, PSMB5, PSMD6, PSMD12, PSMD13, PSMD8, PSMB3 |
| NCI VIF MEDIATED DEGRADATION OF APOBEC3G | PSMC5, TCEB2, PSMA2, PSMB6, PSMC3, PSMB1, PSMC1, PSMA4, PSMD9, PSMB7, PSMA7, PSME1, PSMB2, PSMB5, PSMD2, PSMD6, PSMD13, PSMD12, PSMD8, PSMB3 |
| NCI DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX | PSMC5, PSMA2, PSMB6, PSMC3, PSMB1, PSMC1, PSMA4, PSMD9, PSMB7, PSMA7, PSME1, PSMB2, PSMB5, PSMD2, PSMD6, PSMD13, PSMD12, PSMD8, PSMB3 |
| REACTOME CELL CYCLE CHECKPOINTS | PSMC5, RFC2, PSMA2, CCNB1, PSMB6, PSMC3, ORC4L, PSMB1, PSMC1, PSMD9, PSMB7, RPA3, MAD1L1, RFC5, PSMF1, PSMA7, PSME1, PSMB2, PSMD14, PSMD2, PSMB5, MCM3, PSMD6, PSMD13, PSMD12, CDC25C, UBE2C, PSMD8, PSMB3 |
| NCI REMOVAL OF LICENSING FACTORS FROM ORIGINS | PSMC5, PSMA2, PSMB6, PSMC3, ORC4L, PSMB1, PSMC1, PSMA4, PSMB7, PSMD9, PSMA7, PSME1, PSMD14, PSMB2, PSMD2, PSMB5, MCM3, PSMD6, PSMD13, PSMD12, PSMD8, PSMB3 |
| REACTOME DNA REPLICATION PRE INITIATION | PSMC5, PSMA2, PSMB6, PSMC3, ORC4L, PSMB1, PSMC1, PSMA4, PSMB7, PSMD9, RPA3, PSMA7, PSME1, PSMD14, PSMB2, PSMD2, PSMB5, MCM3, PSMD6, PSMD13, PSMD12, PSMD8, PSMB3 |
| REACTOME ORC1 REMOVAL FROM CHROMATIN | PSMC5, PSMA2, PSMB6, PSMC3, ORC4L, PSMB1, PSMC1, PSMB7, PSMD9, CCNA2, PSMA7, PSME1, PSMB2, PSMB5, MCM3, PSMD2, PSMD6, PSMD13, PSMD12, PSMD8, PSMB3 |
| REACTOME M G1 TRANSITION | PSMC5, PSMA2, PSMB6, PSMC3, ORC4L, PSMB1, PSMC1, PSMA4, PSMB7, PSMD9, PSMA7, PSME1, PSMD14, PSMB2, PSMD2, PSMB5, MCM3, PSMD6, PSMD13, PSMD12, PSMD8, PSMB3 |
| REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | PSMC5, PSMA2, PSMB6, PSMC3, PSMB1, PSMC1, PSMD9, PSMB7, CCNA2, PSMA7, PSME1, PSMB2, PSMB5, PSMD2, PSMD6, PSMD13, PSMD12, PSMD8, PSMB3 |
| BIOCARTA PROTEASOME PATHWAY | PSMB2, PSMB5, PSMA2, PSMB6, PSMB1, PSMA4, PSMB7, PSMB3, PSMA7 |
| PELLICCIOTTA HDAC IN ANTIGEN PRESENTATION UP | COPE, HERPUD1, TMED10, PSMB1, PSMD9, PSMB7, PSMD4, COPZ1, GOSR2, PSMD2, TRAPPC3, PSMD6, PSMD13, PDIA4, YIPF5, PSMB3, TRAPPC4, GOLPH3L, COPB2, BCAP31 |
| CORUM 20S PROTEASOME | PSMB2, PSMB5, PSMB6, PSMB1, PSMA4, PSMB7, PSMB3, PSMA7 |
| BENPORATH PROLIFERATION | CDKN3, PCNA, CHAF1B, ILF2, CEBPG, GART, STMN1, DAP3, PBK, COX4NB, CENPF, PTS, HSPA14, MCM3, LBR, RIT1, SLC25A5, GDI2, GPSM2, PRC1, IDH2, BIRC5 |
| CORUM PA700 COMPLEX | PSMC5, PSMD2, PSMD6, PSMD12, PSMD13, PSMC3, PSMD8, PSMC1, PSMD9, PSMD4 |
| SOTIRIOU BREAST CANCER GRADE 1 VS 3 UP | KIF20A, CDKN3, HN1, PLK1, CDC45L, CCNB1, STMN1, AURKB, MRPL15, HMMR, CCNA2, PSMA7, CDCA3, MCM3, VRK1, CDC20, GMPS, NUDT1, PSMD12, UBE2C, PFDN6, CCT5, NUP93, MELK, RNASEH2A, PRC1, TACC3, STIP1, BIRC5 |
| KANG DOXORUBICIN RESISTANCE UP | CDKN3, PBK, PRC1, HMMR, ZWINT, PLK1, NQO1, BIRC5 |
| WHITEFORD PEDIATRIC CANCER MARKERS | PCNA, HN1, ILF2, NUDT1, TMPO, UBE2C, CCNB1, CDK4, STMN1, MELK, RNASEH2A, PRC1, CCNA2, CENPF, BIRC5 |
| KESHELAVA MULTIPLE DRUG RESISTANCE | SEPX1, TAF12, CCS, MARCH2, GGA2, ODF2, PPP4C, BCAP31, UFC1 |
| REACTOME LAGGING STRAND SYNTHESIS | |
| KEGG RNA DEGRADATION | |
| GRAHAM CML DIVIDING VS NORMAL QUIESCENT UP | |
| PUJANA BRCA1 PCC NETWORK | |
| DANG BOUND BY MYC | |
| LI WILMS TUMOR VS FETAL KIDNEY 1 DN | |
| ROME INSULIN TARGETS IN MUSCLE UP | |
| PUJANA BRCA2 PCC NETWORK | |
| REACTOME REPAIR SYNTHESIS OF PATCH 27 30 BASES LONG BY DNA POLYMERASE | |
| HORIUCHI WTAP TARGETS DN | |
| NCI RNA POLYMERASE II TRANSCRIPTION PRE INITIATION | |
| CHUNG BLISTER CYTOTOXICITY UP | |
| NCI PLK1 PATHWAY | |
| REACTOME NUCLEOTIDE EXCISION REPAIR | |
| OUELLET OVARIAN CANCER INVASIVE VS LMP UP | |
| SANA RESPONSE TO IFNG DN | |
| MOREAUX B LYMPHOCYTE MATURATION BY TACI DN | |
| NCI VIRAL MESSENGER RNA SYNTHESIS | |
| NCI REPAIR SYNTHESIS FOR GAP FILLING BY DNA POLYMERASE IN TC NER | |
| DIAZ CHRONIC MEYLOGENOUS LEUKEMIA UP | |
| FRASOR RESPONSE TO SERM OR FULVESTRANT DN | |
| ZHAN VARIABLE EARLY DIFFERENTIATION GENES DN | |
| REN BOUND BY E2F | |
| CASORELLI ACUTE PROMYELOCYTIC LEUKEMIA DN | |
| RODRIGUES THYROID CARCINOMA POORLY DIFFERENTIATED UP | |
| CORUM RESPIRATORY CHAIN COMPLEX I GAMMA SUBUNIT MITOCHONDRIAL | |
| KRIGE RESPONSE TO TOSEDOSTAT 24HR DN | |
| ALCALA APOPTOSIS | |
| KOBAYASHI EGFR SIGNALING 24HR DN | |
| REACTOME CHOLESTEROL BIOSYNTHESIS | |
| LE EGR2 TARGETS UP | |
| CORUM PA28GAMMA-20S PROTEASOME | |
| CORUM DNA SYNTHESOME COMPLEX 13 SUBUNITS | |
| PENG LEUCINE DEPRIVATION DN | |
| UDAYAKUMAR MED1 TARGETS UP | |
| ZHANG RESPONSE TO CANTHARIDIN DN | |
| REACTOME HOST INTERACTIONS OF HIV FACTORS | |
| REACTOME SYNTHESIS OF DNA | |
| SHEDDEN LUNG CANCER POOR SURVIVAL A6 | |
| TOOKER GEMCITABINE RESISTANCE UP | |
| NCI VPU MEDIATED DEGRADATION OF CD4 | |
| TONKS TARGETS OF RUNX1 RUNX1T1 FUSION MONOCYTE UP | |
| LUI TARGETS OF PAX8 PPARG FUSION | |
| CORUM RESPIRATORY CHAIN COMPLEX I INCOMPLETE INTERMEDIATE MITOCHONDRIAL | |
| REACTOME LATE PHASE OF HIV LIFE CYCLE | |
| CORUM RESPIRATORY CHAIN COMPLEX I INTERMEDIATE VII/650KD MITOCHONDRIAL | |
| HAHTOLA MYCOSIS FUNGOIDES SKIN UP | |
| REACTOME APOPTOSIS | |
| MORI IMMATURE B LYMPHOCYTE DN | |
| TOOKER RESPONSE TO BEXAROTENE DN | |
| DANG MYC TARGETS UP | |
| REACTOME TELOMERE MAINTENANCE | |
| KEGG OXIDATIVE PHOSPHORYLATION | |
| CAFFAREL RESPONSE TO THC 24HR 5 UP | |
| REACTOME MITOTIC PROMETAPHASE | |
| SHEN SMARCA2 TARGETS UP | |
| REACTOME INTEGRATION OF ENERGY METABOLISM | |
| REACTOME POLYMERASE SWITCHING | |
| LASTOWSKA NEUROBLASTOMA COPY NUMBER DN | |
| REACTOME HIV1 TRANSCRIPTION INITIATION | |
| GARY CD5 TARGETS DN | |
| REACTOME METABOLISM OF MRNA | |
| NCI P53REGULATIONPATHWAY | |
| ZHANG BREAST CANCER PROGENITORS UP | |
| MOOTHA FFA OXYDATION | |
| NCI RNA POLYMERASE II TRANSCRIPTION INITIATION | |
| GRADE COLON AND RECTAL CANCER UP | |
| FINETTI BREAST CANCER BASAL VS LUMINAL | |
| NCI RNA POLYMERASE II HIV 1 PROMOTER ESCAPE | |
| REACTOME REGULATION OF INSULIN SECRETION | |
| NCI PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | |
| NCI MRNA SPLICING MAJOR PATHWAY | |
| ZHONG RESPONSE TO AZACITIDINE AND TSA DN | |
| REACTOME G1 S TRANSITION | |
| NCI REPAIR SYNTHESIS OF PATCH 27 30 BASES LONG BY DNA POLYMERASE | |
| MOHANKUMAR TLX1 TARGETS UP | |
| WEI MYCN TARGETS WITH E BOX | |
| MORI LARGE PRE BII LYMPHOCYTE UP | |
| PUJANA BRCA CENTERED NETWORK | |
| ROSTY CERVICAL CANCER PROLIFERATION CLUSTER | KIF20A, PCNA, HN1, ZWINT, TMPO, PLK1, CCNB1, AURKB, CDKN2A, PBK, H2AFX, RPA3, HMMR, CCNA2, CENPF, CDCA3, CDC20, UBE2C, NETO2, LSM4, MELK, PRC1, DPP3, TACC3, KIF2C, EBP, BIRC5 |
| NCI PAUSING AND RECOVERY OF HIV 1 ELONGATION | |
| ACEVEDO LIVER CANCER UP | |
| WONG PROTEASOME GENE MODULE | |
| REACTOME FORMATION AND MATURATION OF MRNA TRANSCRIPT | |
| MOOTHA PGC | |
| NCI MRNA SPLICING MINOR PATHWAY | |
| RICKMAN TUMOR DIFFERENTIATED MODERATELY VS POORLY UP | |
| SONG TARGETS OF IE86 CMV PROTEIN | |
| FUJII YBX1 TARGETS DN | |
| DODD NASOPHARYNGEAL CARCINOMA DN | |
| GAZDA DIAMOND BLACKFAN ANEMIA MYELOID DN | |
| NCI HIV 1 TRANSCRIPTION INITIATION | |
| DANG REGULATED BY MYC UP | |
| CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX 6 | |
| BENPORATH MYC MAX TARGETS | |
| JIANG HYPOXIA CANCER | |
| GRADE COLON CANCER UP | |
| KRIGE RESPONSE TO TOSEDOSTAT 6HR DN | |
| BORCZUK MALIGNANT MESOTHELIOMA UP | |
| MITSIADES RESPONSE TO APLIDIN DN | |
| GRADE METASTASIS DN | |
| RHODES UNDIFFERENTIATED CANCER | |
| ALONSO METASTASIS UP | |
| REACTOME RNA POLYMERASE II TRANSCRIPTION | |
| ZHAN MULTIPLE MYELOMA SUBGROUPS | |
| BASSO B LYMPHOCYTE NETWORK | |
| ODONNELL TARGETS OF MYC AND TFRC DN | |
| MOLENAAR TARGETS OF CCND1 AND CDK4 DN | |
| ZHAN MULTIPLE MYELOMA PR UP | |
| REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | |
| BUYTAERT PHOTODYNAMIC THERAPY STRESS DN | |
| REACTOME MRNA SPLICING | |
| LOPEZ MBD TARGETS | |
| REACTOME GLOBAL GENOMIC NER | |
| REACTOME RNA POLYMERASE I III AND MITOCHONDRIAL TRANSCRIPTION | |
| YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 10 | |
| MARKEY RB1 ACUTE LOF DN | |
| BASAKI YBX1 TARGETS UP | |
| REACTOME ELONGATION AND PROCESSING OF CAPPED TRANSCRIPTS | |
| LOCKWOOD AMPLIFIED IN LUNG CANCER | |
| CORUM PA28-20S PROTEASOME | |
| REACTOME TRANSCRIPTION COUPLED NER | |
| NCI MRNA CAPPING | |
| NCI RNA POLYMERASE II TRANSCRIPTION | |
| NCI MITOTIC PROMETAPHASE | |
| CROONQUIST NRAS SIGNALING DN | |
| KEGG PYRIMIDINE METABOLISM | |
| ENK UV RESPONSE KERATINOCYTE UP | |
| REACTOME DNA REPAIR | |
| GUTIERREZ MULTIPLE MYELOMA DN | |
| REACTOME METABOLISM OF RNA | |
| CORUM CDC5L COMPLEX | |
| SCHLOSSER MYC TARGETS REPRESSED BY SERUM | |
| PENG GLUTAMINE DEPRIVATION DN | |
| NCI HIV 1 TRANSCRIPTION ELONGATION | |
| REACTOME HIV INFECTION | |
| KAUFFMANN DNA REPAIR GENES | |
| NCI PAUSING AND RECOVERY OF TAT MEDIATED HIV 1 ELONGATION | |
| NCI BARD1PATHWAY | |
| MOOTHA TCA | |
| CHEMNITZ RESPONSE TO PROSTAGLANDIN E2 UP | |
| PUJANA XPRSS INT NETWORK | |
| FURUKAWA DUSP6 TARGETS PCI35 DN | |
| NCI POLYMERASE SWITCHING | |
| BENPORATH CYCLING GENES | |
| RAMALHO STEMNESS UP | |
| REACTOME RNA POLYMERASE I PROMOTER CLEARANCE | |
| HONMA DOCETAXEL RESISTANCE | |
| DING LUNG CANCER EXPRESSION BY COPY NUMBER | |
| MARTINEZ RESPONSE TO TRABECTEDIN UP | |
| KEGG PARKINSONS DISEASE | |
| WINNEPENNINCKX MELANOMA METASTASIS UP | |
| NCI ELONGATION OF INTRON CONTAINING TRANSCRIPTS AND CO TRANSCRIPTIONAL MRNA SPLICING | |
| SCHUHMACHER MYC TARGETS UP | |
| LEE LIVER CANCER SURVIVAL DN | |
| MUELLER PLURINET | |
| TOYOTA TARGETS OF MIR34B AND MIR34C | |
| CORUM 39S RIBOSOMAL SUBUNIT MITOCHONDRIAL | MRPL17, MRPL23, MRPL35, MRPL40, MRPL34, MRPL16, MRPL15, MRPL46, MRPL28, MRPL18 |
| MANALO HYPOXIA DN | |
| DAIRKEE TERT TARGETS UP | |
| NCI RNA POLYMERASE II PROMOTER ESCAPE | |
| NCI ABORTIVE ELONGATION OF HIV 1 TRANSCRIPT IN THE ABSENCE OF TAT | |
| LUI THYROID CANCER CLUSTER 3 | |
| RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY UP | |
| CORUM CNS-P53 COMPLEX | |
| REACTOME EXTENSION OF TELOMERES | |
| RICKMAN METASTASIS UP | |
| SPIELMAN LYMPHOBLAST EUROPEAN VS ASIAN DN | |
| KAAB FAILED HEART ATRIUM DN | |
| REACTOME MRNA SPLICING MINOR PATHWAY | |
| CORUM 26S PROTEASOME | |
| BIDUS METASTASIS UP | |
| WEST ADRENOCORTICAL TUMOR UP | |
| YU MYC TARGETS UP | |
| CORUM RESPIRATORY CHAIN COMPLEX I LAMBDA SUBUNIT MITOCHONDRIAL | |
| NCI POLYMERASE SWITCHING ON THE C STRAND OF THE TELOMERE | |
| CROONQUIST IL6 DEPRIVATION DN | |
| CHIANG LIVER CANCER SUBCLASS PROLIFERATION UP | |
| LASTOWSKA NEUROBLASTOMA COPY NUMBER UP | |
| KINSEY TARGETS OF EWSR1 FLII FUSION UP | |
| DACOSTA UV RESPONSE VIA ERCC3 UP | |
| NCI TELOMERE C STRAND LAGGING STRAND SYNTHESIS | |
| CORUM 55S RIBOSOME MITOCHONDRIAL | MRPS7, MRPS34, MRPS12, MRPS16, MRPL17, MRPL23, MRPL35, MRPS11, MRPS33, DAP3, MRPL40, MRPL15, MRPS28, MRPL28, MRPL18, MRPL16, MRPL34, MRPL46 |
| CAFFAREL RESPONSE TO THC 24HR 5 DN | |
| REACTOME S PHASE | |
| ACEVEDO NORMAL TISSUE ADJACENT TO LIVER TUMOR DN | |
| FINETTI BREAST CANCER KINOME RED | |
| CHANG CYCLING GENES | RANGAP1, CDKN3, MELK, TACC3, ILF2, UBE2C, ZNHIT2 |
| CORUM 28S RIBOSOMAL SUBUNIT MITOCHONDRIAL | |
| MOREAUX MULTIPLE MYELOMA BY TACI DN | |
| BOYAULT LIVER CANCER SUBCLASS G3 UP | |
| NCI FORMATION AND MATURATION OF MRNA TRANSCRIPT | |
| FARMER BREAST CANCER CLUSTER 2 | |
| OUELLET CULTURED OVARIAN CANCER INVASIVE VS LMP UP | |
| RHODES CANCER META SIGNATURE | |
| NCI RNA POLYMERASE II TRANSCRIPTION INITIATION AND PROMOTER CLEARANCE | |
| REACTOME TRANSCRIPTION | |
| NCI HIV 1 TRANSCRIPTION PRE INITIATION | |
| NCI SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE | |
| PUJANA BREAST CANCER WITH BRCA1 MUTATED UP | |
| REACTOME HIV LIFE CYCLE | |
| REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | |
| AMUNDSON GAMMA RADIATION RESPONSE | |
| NCI TRANSCRIPTION OF THE HIV GENOME | |